Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

(2015) Azadeh Karami et al.   Alzheimers & Dementia

Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations

(2015) Camila Orellana et al.   Neurodegenerative Diseases

Cell encapsulation: technical and clinical advances

(2015) Gorka Orive et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease

(2014) Michael S. Rafii et al.   Alzheimers & Dementia

Regulated Extracellular Choline Acetyltransferase Activity— The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway

(2013) Swetha Vijayaraghavan et al.   PLoS One

Human Neural Stem Cells Genetically Modified to Express Human Nerve Growth Factor (NGF) Gene Restore Cognition in the Mouse with Ibotenic Acid-Induced Cognitive Dysfunction

(2012) Hong J. Lee et al.   CELL TRANSPLANTATION

Encapsulated Cell Biodelivery of Nerve Growth Factor to the Basal Forebrain in Patients with Alzheimer’s Disease

(2012) Maria Eriksdotter-Jönhagen et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management

(2012) Laura McKelvey et al.   JOURNAL OF NEUROCHEMISTRY

Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery

(2012) Lars U. Wahlberg et al.   JOURNAL OF NEUROSURGERY

Avoidance of Electrode Related MRI Artifact during Staged Deep Brain Stimulator Implantation

(2012) Cole Giller et al.   Journal of Neurological Surgery Part A-Central European Neurosurgery

Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer

(2011) L Fjord-Larsen et al.   GENE THERAPY

The expanding universe of transposon technologies for gene and cell engineering

(2011) Zoltán Ivics et al.   Mobile DNA

Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson’s disease

(2010) R. Constantinescu et al.   ACTA NEUROLOGICA SCANDINAVICA

The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease : experience from the first 24 months

(2010) Andrew Simmons et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Long-term Delivery of Nerve Growth Factor by Encapsulated Cell Biodelivery in the Göttingen Minipig Basal Forebrain

(2010) Lone Fjord-Larsen et al.   MOLECULAR THERAPY

Development of a Non Invasive NGF-Based Therapy for Alzheimers Disease

(2009) Sonia Covaceuszach et al.   Current Alzheimer Research

Cholinergic Involvement in Alzheimer’s Disease. A Link with NGF Maturation and Degradation

(2009) A. Claudio Cuello et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates

(2009) Lajos Mátés et al.   NATURE GENETICS

Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons

(2008) Kathie M. Bishop et al.   EXPERIMENTAL NEUROLOGY

Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine

(2006) T. Darreh-Shori et al.   NEUROBIOLOGY OF AGING